Perioperative Cardiac Risk Management

This chapter explores the management of cardiac risks associated with surgery, focusing on acute calculus cholecystitis and the latest guidelines from the 2024 ACC AHA. It examines the importance of biomarker testing, specifically troponin and pro BNP, and the complexities surrounding their interpretation in high-risk patients. Additionally, it discusses the implications of myocardial injury post-surgery, the management of new-onset atrial fibrillation, and the necessity of collaboration with cardiology for optimal patient outcomes.